Δ
Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race’s June 2022 Quarterly Investor Briefing followed by a Q&A session.
Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett. https://youtu.be/sIgOxKGC6Cg
June-2022-Quarterly-Activity-ReportDownload